Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Observer-Blind, Randomized Multicenter Study to Evaluate the Safety of Trivalent Subunit Influenza Vaccines, Produced Either in Mammalian Cell Culture (TIVc) or in Embryonated Eggs (TIV), in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related Complications

NCT01998477 is registered in ClinicalTrials.gov with Novartis Vaccines as lead sponsor.

NCT NCT01998477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01998477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Observer-Blind, Randomized Multicenter Study to Evaluate the Safety of Trivalent Subunit Influenza Vaccines, Produced Either in Mammalian Cell Culture (TIVc) or in Embryonated Eggs (TIV), in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related Complications
Lead sponsor
Novartis Vaccines
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2013
Completion date
July 31, 2014
Enrollment
430 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

influenza